ニュース

Shares of UnitedHealth Group slipped on Monday after Berkshire Hathaway revealed in a regulatory filing that it divested from the healthcare giant during the first quarter.

TPU sales are starting to have a huge impact on Alphabet's growth rates.

LyondellBasell (LYB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

In the past quarter, NuScale Power reported Q1 2026 sales of US$565,000 versus US$13.38 million a year earlier, with net loss widening to US$44.02 million and basic loss per share from continuing operations rising to US$0.14. At the same time, NuScale is pressing ahead with large-scale SMR commercialization efforts and facing heightened legal scrutiny over alleged misleading partnership disclosures, creating a complex mix of operational progress and risk for investors to weigh. Next, we’ll...

Investing.com -- Seagate Technology Holdings (NASDAQ:STX) shares fell 7.5% Monday after Chief Executive Officer Dave Mosley said building new factories would "take too long" during a presentation at the JPMorgan Global Technology, Media and Communications Conference.

Western Digital sees a bright future for HDD.

Starbucks is trying to bring customers back to its coffeehouses, but the company’s turnaround is coming at the cost of yet another painful message for its workers. Away from the coffee houses, this time the Seattle-based coffee giant is going for corporate jobs and closing several regional support ...

NU Holdings' shares dip after Q1 earnings miss estimates. Customer growth, AI expansion and a record $5B revenue quarter highlight the momentum.

Bank of America (NYSE:BAC) just made one of the more contrarian calls on Wall Street regarding the enterprise software giant. Analyst Tal Liani reinstated coverage of Salesforce (NYSE:CRM) with an Underperform rating and a $160 price target, a notable bear take on a stock that still carries a consensus average price target of $268.05. For ... BofA Slaps Salesforce With Underperform Rating, $160 Price Target: Is the AI Story Falling Flat?

Bitcoin Depot (NASDAQ: $BTM), the largest operator of Bitcoin (CRYPTO: $BTC) ATMs in North America, has filed for C...

XPeng's new robotaxi offers an indirect validation of Tesla's approach to developing self-driving cars. On Monday, XPeng stock fell around 4%.

Lumentum Holdings and Coherent shares fell Monday after investor Leopold Aschenbrenner disclosed he exited stakes in the optical-networking companies.

First, the SpaceX IPO inspired space investors -- but today it's frightening them.

A major analyst just offered a bull case for Boeing (NYSE:BA) stock, framing the recent aerospace selloff as a buying window for patient investors. Citi raised its price target on Boeing to $260 from $256 and reiterated a Buy rating, with the firm telling clients the real opportunity lies in the dislocation itself. The call ... Citi Calls the Aerospace Selloff a Gift, Raises Boeing Price Target to $260

Shares of FuelCell Energy (NASDAQ:FCEL) slid 22% in Monday morning trading, while Plug Power (NASDAQ:PLUG) shares dropped 12%. The selloff hits two of the loudest winners of the AI power trade. The hydrogen rally is taking a breather after weeks of euphoric upside. The pullback comes after a remarkable run. FuelCell Energy stock has surged ... FuelCell Energy Slumps 22%, Plug Power Sinks 12%: Hydrogen Bulls Hit the Brakes

Company trims workforce while increasing investment in artificial intelligence

First the SpaceX IPO got investors excited. Now it may be getting them scared.

Greg Abel exited positions including Visa, Mastercard, Amazon, and UnitedHealth while boosting Berkshire's Alphabet stake to almost 58 million shares

Greg Abel exited positions including Visa, Mastercard, Amazon, and UnitedHealth while boosting Berkshire's Alphabet stake to almost 58 million shares

Starbucks stock inched higher on Friday as management announced layoffs and the closure of regional offices. TD Cowen recommends buying SBUX shares at current levels.

Is it time to sell other space stocks and buy SpaceX instead?

Shares of Regeneron Pharmaceuticals are down about 11%, dragging the Nasdaq composite, after the company’s experimental melanoma drug failed a pivotal clinical trial. The company said that its drug fianlimab, when combined with an approved cancer drug, didn't keep patients’ disease from worsening significantly longer than Merck’s Keytruda.

Jefferies Starts Coverage With Underperform RatingMobileye Global (NASDAQ:MBLY) faces potential downside risks tied to structural industry challenges and customer concentration, according to Jefferies, which initiated coverage on the stock with an “underperform” rating and an $8 price target. The target implies roughly 24% downside from the stock’s previous closing price of $10.

Oil prices may cool after an Iran ceasefire, but these energy stocks could still outperform; these three stocks remain attractive buys

The S&P 500 Index ($SPX ) (SPY ) today is up +0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. June E-mini S&P futures (ESM26 ) are up +0.10%, and June E-mini Nasdaq futures...

Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector’s short history, and bargain hunters are circling the wreckage. But here’s what you should actually be watching. The Q1 2026 release on May 11, 2026 was a fracture. EPS came in ... Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead

Regeneron Pharmaceuticals stock crashed Monday after its experimental melanoma treatment failed in Phase 3 testing.